CN104397788B - 一种人参菌类保健饮料 - Google Patents
一种人参菌类保健饮料 Download PDFInfo
- Publication number
- CN104397788B CN104397788B CN201410584063.6A CN201410584063A CN104397788B CN 104397788 B CN104397788 B CN 104397788B CN 201410584063 A CN201410584063 A CN 201410584063A CN 104397788 B CN104397788 B CN 104397788B
- Authority
- CN
- China
- Prior art keywords
- kilogram
- vitamin
- ginseng
- mass fraction
- yellow solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000208340 Araliaceae Species 0.000 title claims abstract description 36
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 36
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 36
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 36
- 235000013361 beverage Nutrition 0.000 title claims abstract description 18
- 241000233866 Fungi Species 0.000 title claims abstract description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 27
- 230000001954 sterilising effect Effects 0.000 claims abstract description 18
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 244000144927 Aloe barbadensis Species 0.000 claims abstract description 12
- 235000002961 Aloe barbadensis Nutrition 0.000 claims abstract description 12
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 11
- 240000000588 Hericium erinaceus Species 0.000 claims abstract description 10
- 235000007328 Hericium erinaceus Nutrition 0.000 claims abstract description 10
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 10
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims abstract description 9
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 9
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 9
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 9
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000001630 malic acid Substances 0.000 claims abstract description 9
- 235000011090 malic acid Nutrition 0.000 claims abstract description 9
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000001509 sodium citrate Substances 0.000 claims abstract description 9
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 9
- 239000000811 xylitol Substances 0.000 claims abstract description 9
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 9
- 229960002675 xylitol Drugs 0.000 claims abstract description 9
- 235000010447 xylitol Nutrition 0.000 claims abstract description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 8
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 8
- 239000011718 vitamin C Substances 0.000 claims abstract description 8
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 7
- 229930006000 Sucrose Natural products 0.000 claims abstract description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 7
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 7
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 7
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 7
- 238000007789 sealing Methods 0.000 claims abstract description 5
- 230000036541 health Effects 0.000 claims description 17
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 14
- 244000309464 bull Species 0.000 claims description 9
- 239000000686 essence Substances 0.000 claims description 8
- 241000221377 Auricularia Species 0.000 claims description 7
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 7
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 7
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000011049 filling Methods 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000012859 sterile filling Methods 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 235000011083 sodium citrates Nutrition 0.000 claims description 2
- 244000060234 Gmelina philippensis Species 0.000 claims 1
- 241000577951 Hydnum Species 0.000 claims 1
- 244000173166 Pyrus ussuriensis Species 0.000 claims 1
- 235000011572 Pyrus ussuriensis Nutrition 0.000 claims 1
- 238000007654 immersion Methods 0.000 claims 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 15
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract description 9
- 235000019158 vitamin B6 Nutrition 0.000 abstract description 9
- 229940011671 vitamin b6 Drugs 0.000 abstract description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 230000032683 aging Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 235000012000 cholesterol Nutrition 0.000 abstract description 3
- 229940109850 royal jelly Drugs 0.000 abstract description 2
- 244000028550 Auricularia auricula Species 0.000 abstract 1
- 235000000023 Auricularia auricula Nutrition 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 235000011399 aloe vera Nutrition 0.000 abstract 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 abstract 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 abstract 1
- 229960004106 citric acid Drugs 0.000 abstract 1
- 238000011068 loading method Methods 0.000 abstract 1
- 229930014626 natural product Natural products 0.000 abstract 1
- 239000008213 purified water Substances 0.000 abstract 1
- 229960001790 sodium citrate Drugs 0.000 abstract 1
- 230000006870 function Effects 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- 229920000057 Mannan Polymers 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- 210000003360 nephrocyte Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- QHBZHVUGQROELI-SOFGYWHQSA-N (E)-10-hydroxydec-2-enoic acid Chemical compound OCCCCCCC\C=C\C(O)=O QHBZHVUGQROELI-SOFGYWHQSA-N 0.000 description 1
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 101710190529 Insulin-like peptide Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 208000020358 Learning disease Diseases 0.000 description 1
- QHBZHVUGQROELI-UHFFFAOYSA-N Royal Jelly acid Natural products OCCCCCCCC=CC(O)=O QHBZHVUGQROELI-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000003555 analeptic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000003723 learning disability Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- AQCHWTWZEMGIFD-UHFFFAOYSA-N metolazone Chemical compound CC1NC2=CC(Cl)=C(S(N)(=O)=O)C=C2C(=O)N1C1=CC=CC=C1C AQCHWTWZEMGIFD-UHFFFAOYSA-N 0.000 description 1
- 230000004682 mucosal barrier function Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明公开了一种人参菌类保健饮料，每1000升纯净水中加入人参0.1‑12千克、猴头菇0.1‑7千克、库拉索芦荟汁2‑15千克、黑木耳0.3千克、白砂糖0‑110千克、维生素B6 0.0003‑0.003千克、维生素C 0.0001千克、蜂王浆0.1‑5千克、枸杞2‑10千克以及少量的木糖醇、羧甲基纤维素钠、柠檬酸、柠檬酸钠、山梨酸钾、质量分数为1％的柠檬黄溶液、质量分数为1％的日落黄溶液、苹果酸、人参香精。本发明以天然产品为原料，经过高温杀菌、灌装封口再二次杀菌制得人参菌类保健饮料，能够提高人体免疫能力、抗肿瘤、降血糖、降低胆固醇、延缓衰老、抗疲劳等，起到保健作用。
Description
技术领域
本发明涉及保健饮料领域，具体是一种人参菌类保健饮料。
背景技术
目前市场上销售的抗疲劳型功能型饮料大多数含有咖啡因、牛磺酸等兴奋剂成分，长期服用会产生依赖。
发明内容
本发明的目的在于提供一种人参菌类保健饮料，采用天然产品作为原料，提高了产品的吸收率，具有保健效果。
为实现上述目的，本发明提供如下技术方案：
一种人参菌类保健饮料，每1000升纯净水中加入人参0.1-12千克、猴头菇0.1-7千克、库拉索芦荟汁2-15千克、黑木耳0.3千克、白砂糖0-110千克、柠檬酸1-3千克、柠檬酸钠0.3-20千克、山梨酸钾0.1-0.3千克、质量分数为1％的柠檬黄溶液0.5-3千克、质量分数为1％的日落黄溶液0.05-3千克、苹果酸0.2-1千克、维生素B6 0.0003-0.003千克、维生素C 0.0001千克、人参香精0.1-0.9千克、蜂王浆0.1-5千克、木糖醇0.1-50千克、羧甲基纤维素钠2-3千克和枸杞2-10千克。
作为本发明进一步的方案：每1000升纯净水中人参的用量为0.1-12千克。
作为本发明进一步的方案：每1000升纯净水中猴头菇的用量为0.1-7千克。
作为本发明进一步的方案：每1000升纯净水中库拉索芦荟汁的用量为2-15千克。
作为本发明进一步的方案：每1000升纯净水中维生素B6的用量为0.0003-0.009千克。
作为本发明进一步的方案：每1000升纯净水中维生素C的用量为0.0001千克。
作为本发明进一步的方案：每1000升纯净水中人参的用量为0.1-12千克。
所述的人参菌类保健饮料的制备方法，其特征在于，步骤如下：
(1)将人参、枸杞、猴头菇、黑木耳粉碎至200目以下，再放入预先加热到85℃的纯净水中浸泡20min，过滤；
(2)将过滤后的溶液倒入混合机，加入白砂糖、库拉索芦荟汁、柠檬酸、柠檬酸钠、山梨酸钾、质量分数为1％的柠檬黄溶液、质量分数为1％的日落黄溶液、苹果酸、维生素B6、维生素C、人参香精、木糖醇和羧甲基纤维素钠进行混合后，经超高温瞬时灭菌机132℃温度下杀菌3-4s后，待冷却缸冷却至30℃加蜂王浆；
(3)将步骤(2)得到的溶液灌装到玻璃瓶，玻璃瓶灌装封口后，放到杀菌釜中二次蒸汽杀菌20min，然后降温到30℃以下，吹干，打码、包装入库。
作为本发明进一步的方案：所述步骤(1)中的过滤采用200目双联过滤器，所述步骤(2)中超高温瞬时灭菌机为美国UST超高温瞬时灭菌机，所述步骤(3)中的灌装采用低温无菌灌装机。
本发明中，主要成分的作用如下：
1、人参：经现代医学证明其药用价值极高，具有补气强身、益智安神、延年益寿、美容的显著功效。
2、猴头菇：中医认为，猴头菇有增进食欲，增强胃粘膜屏障机能，提高淋巴细胞转化率，提升白细胞等作用，故可以提高人体对疾病的免疫能力。
3、库拉索芦荟：库拉索芦荟中的粘稠物质多糖类(乙酰化葡甘聚糖、甘露聚糖、乙酰化甘露聚糖、aloemannan、alocutin、alomicin等)具有提高免疫力和抑制、破坏异常细胞的生长的作用，起到抗肿瘤的作用。
4、蜂王浆：辅助降低血糖，此作用主要因其含有的胰岛素样肽类推理得来，胰岛素样肽类是治疗糖尿病的特效药物；抗氧化功能，它对细胞的修复以及再生具有很强的作用，在蜂王浆中检测出的超氧化物歧化酶是抗氧化的主要成分；降低血脂，蜂王浆含有人体必需的维生素达10种以上，能平衡脂肪代谢和糖代谢，可降低肥胖者的高血脂和高血糖，非常适合肥胖型糖尿病患者；控制血管扩张、降低血压作用，源自蜂王浆中所含的10-羟基-癸烯酸(王浆酸)以及王浆主要蛋白-1；抗衰老作用和强化性功能作用，同时还有抗辐射，增强记忆力的作用。
5、维生素B6：主要作用在人体的血液、肌肉、神经、皮肤等。维生素B6的功能有抗体的合成、消化系统中胃酸的制造、脂肪与蛋白质利用、维持钠/钾平衡。缺乏维生素B6的通症，一般缺乏时会有食欲不振、食物利用率低、失重、呕吐、下痢等毛病，严重缺乏者会有粉刺、贫血、关节炎、小孩痉挛、忧郁、头痛、掉发、易发炎、学习障碍、衰弱等症状。
6、黑木耳：美国科学家研究发现，黑木耳可抑制血小板凝聚，降低血液中胆固醇的含量，对冠心病、动脉血管硬化、脑心血管病颇为有益，并有一定的抗癌作用。黑木耳中的胶质，还可将残留在人体消化系统内的灰尘杂质吸附聚集，排出体外，起清肠胃的作用。
7、枸杞：具有补肾功能，在老年鼠肾线粒体的老化实验中，通过观察应用枸杞多糖、维生素E-C合剂等抗衰老药物后，老年鼠肾细胞线粒体超微结构、三磷酸腺苷ATP合成量以及脂质过氧化产物丙二醛水平的改变，发现老年鼠肾线粒体的结构和功能变化伴随着自由基代谢产物丙二醛的增高，老年鼠肾细胞线粒体三磷酸腺苷ATP合成量为120.38nM/mgPrmin±16.72nM/mgPrmin，较青年组低18.75nM/mgPrmin；而肾组织丙二醛为30.40μg/100mg±6.66μg/100mg湿重，是青年组的2.4倍。长期服用维生素E-C合剂或枸杞多糖均可在一定程度上起到对抗自由基的作用，使肾组织丙二醛水平下降，预防线粒体老化，使其功能有所改善。
与现有技术相比，本发明的有益效果是：
本发明以天然产品为原料，不添加激素类、化学类及对人体有副作用的产品，具有提高人体免疫能力、抗肿瘤、降血糖、降低胆固醇、延缓衰老、抗疲劳等特点，起到保健作用。
本发明不仅增加了保健饮料市场的选择性，而且该饮料配方采用天然产品，将药食同源的产品融入日常饮食当中，提高了产品的吸收率，扩大了市场销售份额，极具有开发潜力。
具体实施方式
下面将结合本发明实施例，对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1
本发明实施例中，一种人参菌类保健饮料，每1000升纯净水中加入人参0.1千克、猴头菇7千克、库拉索芦荟汁2千克、黑木耳0.3千克、白砂糖110千克、柠檬酸3千克、柠檬酸钠0.3千克、山梨酸钾0.1千克、质量分数为1％的柠檬黄溶液3千克、质量分数为1％的日落黄溶液0.05千克、苹果酸1千克、维生素B6 0.0003千克、维生素C 0.0001千克、人参香精0.3千克、蜂王浆5千克、木糖醇0.1千克、羧甲基纤维素钠2千克和枸杞10千克。
所述的人参菌类保健饮料的制备方法，其特征在于，步骤如下：
(1)将人参、枸杞、猴头菇、黑木耳粉碎至200目以下，再放入预先加热到85℃的纯净水中浸泡20min，用200目双联过滤器过滤；
(2)将过滤后的溶液倒入混合机，加入白砂糖、库拉索芦荟汁、柠檬酸、柠檬酸钠、山梨酸钾、质量分数为1％的柠檬黄溶液、质量分数为1％的日落黄溶液、苹果酸、维生素B6、维生素C、人参香精、木糖醇和羧甲基纤维素钠进行混合后，经美国UST超高温瞬时灭菌机132℃温度下杀菌3-4s后，在冷却缸冷却至30℃加蜂王浆；
(3)用低温无菌灌装机将步骤(2)得到的溶液灌装到玻璃瓶，玻璃瓶灌装封口后，放到杀菌釜中二次蒸汽杀菌20min，然后降温到30℃以下，吹干，打码、包装入库。
本发明实施例适合没有糖尿病的人饮用，本发明实施例的保质期为24个月。
实施例2
本发明实施例中，一种人参菌类保健饮料，每1000升纯净水中加入人参10千克、猴头菇7千克、库拉索芦荟汁15千克、黑木耳0.3千克、柠檬酸1千克、柠檬酸钠0.3千克、山梨酸钾0.1千克、质量分数为1％的柠檬黄溶液0.5千克、质量分数为1％的日落黄溶液0.05千克、苹果酸1千克、维生素B6 0.003千克、维生素C 0.0001千克、人参香精0.1千克、蜂王浆5千克、木糖醇50千克、羧甲基纤维素钠2千克和枸杞2千克。
所述的人参菌类保健饮料的制备方法，其特征在于，步骤如下：
(1)将人参、枸杞、猴头菇、黑木耳粉碎至200目以下，再放入预先加热到85℃的纯净水中浸泡20min，用200目双联过滤器过滤；
(2)将过滤后的溶液倒入混合机，加入库拉索芦荟汁、柠檬酸、柠檬酸钠、山梨酸钾、质量分数为1％的柠檬黄溶液、质量分数为1％的日落黄溶液、苹果酸、维生素B6、维生素C、人参香精、木糖醇和羧甲基纤维素钠进行混合后，经美国UST超高温瞬时灭菌机132℃温度下杀菌3-4s后，在冷却缸冷却至30℃加蜂王浆；
(3)用低温无菌灌装机将步骤(2)得到的溶液灌装到玻璃瓶，玻璃瓶灌装封口后，放到杀菌釜中二次蒸汽杀菌20min，然后降温到30℃以下，吹干，打码、包装入库。
本发明实施例适合糖尿病患者饮用，本发明实施例的保质期为24个月。
本发明以天然产品为原料，不添加激素类、化学类及对人体有副作用的产品，具有提高人体免疫能力、抗肿瘤、降血糖、降低胆固醇、延缓衰老、抗疲劳等特点，起到保健作用。
本发明不仅增加了保健饮料市场的选择性，而且该饮料配方采用天然产品，将药食同源的产品融入日常饮食当中，提高了产品的吸收率，扩大了市场销售份额，极具有开发潜力。
对于本领域技术人员而言，显然本发明不限于上述示范性实施例的细节，而且在不背离本发明的精神或基本特征的情况下，能够以其他的具体形式实现本发明。因此，无论从哪一点来看，均应将实施例看作是示范性的，而且是非限制性的，本发明的范围由所附权利要求而不是上述说明限定，因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
此外，应当理解，虽然本说明书按照实施方式加以描述，但并非每个实施方式仅包含一个独立的技术方案，说明书的这种叙述方式仅仅是为清楚起见，本领域技术人员应当将说明书作为一个整体，各实施例中的技术方案也可以经适当组合，形成本领域技术人员可以理解的其他实施方式。
Claims (3)
1.一种人参菌类保健饮料，其特征在于，每1000升纯净水中加入人参0.1-12千克、猴头菇0.1-7千克、库拉索芦荟汁2-15千克、黑木耳0.3千克、白砂糖0-110千克、柠檬酸1-3千克、柠檬酸钠0.3-20千克、山梨酸钾0.1-0.3千克、质量分数为1％的柠檬黄溶液0.5-3千克、质量分数为1％的日落黄溶液0.05-3千克、苹果酸0.2-1千克、维生素B60.0003-0.003千克、维生素C 0.0001千克、人参香精0.1-0.9千克、蜂王浆0.1-5千克、木糖醇0.1-50千克、羧甲基纤维素钠2-3千克和枸杞2-10千克。
2.根据权利要求1所述的人参菌类保健饮料的制备方法，其特征在于，步骤如下：
(1)将人参、枸杞、猴头菇、黑木耳粉碎至200目以下，再放入预先加热到85℃的纯净水中浸泡20min，过滤；
(2)将过滤后的溶液倒入混合机，加入白砂糖、库拉索芦荟汁、柠檬酸、柠檬酸钠、山梨酸钾、质量分数为1％的柠檬黄溶液、质量分数为1％的日落黄溶液、苹果酸、维生素B6、维生素C、人参香精、木糖醇和羧甲基纤维素钠进行混合后，经超高温瞬时灭菌机132℃温度下杀菌3-4s后，待冷却缸冷却至30℃加蜂王浆；
(3)将步骤(2)得到的溶液灌装到玻璃瓶，玻璃瓶灌装封口后，放到杀菌釜中二次蒸汽杀菌20min，然后降温到30℃以下，吹干，打码、包装入库。
3.根据权利要求2所述的人参菌类保健饮料的制备方法，其特征在于，所述步骤(1)中的过滤采用200目双联过滤器，所述步骤(2)中超高温瞬时灭菌机为美国UHT超高温瞬时灭菌机，所述步骤(3)中的灌装采用低温无菌灌装机。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410584063.6A CN104397788B (zh) | 2014-10-16 | 2014-10-16 | 一种人参菌类保健饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410584063.6A CN104397788B (zh) | 2014-10-16 | 2014-10-16 | 一种人参菌类保健饮料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104397788A CN104397788A (zh) | 2015-03-11 |
| CN104397788B true CN104397788B (zh) | 2017-01-11 |
Family
ID=52635510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410584063.6A Active CN104397788B (zh) | 2014-10-16 | 2014-10-16 | 一种人参菌类保健饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104397788B (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104872320A (zh) * | 2015-05-27 | 2015-09-02 | 济南方宇文化传媒有限公司 | 缓解压力过大造成的头痛的饮品及其制备方法 |
| CN105584965B (zh) * | 2015-12-28 | 2018-02-27 | 车兴义 | 玻璃瓶灌装植物蛋白饮料的拉环盖密封方法及拉环盖 |
| CN106306893A (zh) * | 2016-08-22 | 2017-01-11 | 广州加维舒医药有限公司 | 人参维生素饮品及其加工方法 |
| CN111685248A (zh) * | 2019-03-14 | 2020-09-22 | 广州荟博大健康产业有限公司 | 一种芦荟原汁饮品及其制备方法 |
| CN110574853A (zh) * | 2019-10-17 | 2019-12-17 | 北京汉后中医研究院 | 一种人参猴头菇阿胶复合饮品 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1066929C (zh) * | 1996-03-14 | 2001-06-13 | 赵吉发 | 一种保健饮料及其制造方法 |
| CN1276732C (zh) * | 2004-04-02 | 2006-09-27 | 戚向阳 | 一种蜂皇浆保健饮品及其制备方法 |
| CN101518336A (zh) * | 2009-04-14 | 2009-09-02 | 北京惠中铭捷生物科技有限公司 | 一种具有抗氧化功能的营养食品及其制备方法 |
| CN101695513B (zh) * | 2009-10-28 | 2011-12-14 | 上海永神生物科技有限公司 | 一种具有抗肿瘤作用的组合物及其应用 |
| KR20110119305A (ko) * | 2010-04-27 | 2011-11-02 | 김원규 | 타우린, 비타민류, 로얄젤리, 홍삼, 구기자, 글루메이트 (탈지미강, 미베아) 및 애플 에센스를 주성분으로 함유하는 기능성 음료조성물 |
| CN102318867B (zh) * | 2011-08-20 | 2012-11-28 | 福建省幸福生物科技有限公司 | 具有抗疲劳功能的参茶饮料及其制备方法 |
| CN102318868B (zh) * | 2011-08-26 | 2013-01-23 | 吉林紫鑫药业股份有限公司 | 人参枸杞苹果饮料及其生产工艺 |
| CN103156255B (zh) * | 2013-02-04 | 2015-01-07 | 张清明 | 健心脑耳肽保健食品和饮品系列产品及其制作方法 |
-
2014
- 2014-10-16 CN CN201410584063.6A patent/CN104397788B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN104397788A (zh) | 2015-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104397788B (zh) | 一种人参菌类保健饮料 | |
| CN102511869B (zh) | 红枣生姜浓浆 | |
| CN106666312A (zh) | 一种辅助降血糖的保健食品及其颗粒剂和胶囊剂制备方法 | |
| CN108112973A (zh) | 一种辅助降三高组合物及其制备方法 | |
| CN107319086A (zh) | 一种枸杞金丝皇菊压片糖果及其制备方法 | |
| CN107455625A (zh) | 一种具有抗疲劳减肥功能的植物营养素饮料及其制备工艺 | |
| CN102349963A (zh) | 一种预防微血栓形成的保健品及其制备方法 | |
| CN106723015A (zh) | 一种具有抗疲劳和抗氧化功能的保健食品及其制备工艺 | |
| CN105747073A (zh) | 一种药食同源植物固体饮料及其制备方法 | |
| CN108185441A (zh) | 一种治疗糖尿病的配方食品及其制备方法 | |
| CN101507800A (zh) | 金线莲和南瓜复合降血糖保健品及其制备方法 | |
| JPH06237735A (ja) | 血糖降下作用を有する食品 | |
| CN103725574A (zh) | 一种金樱杞子酒的制备方法及其保健功能和用途 | |
| CN111467468A (zh) | 一种含人参、蛹虫草、生姜、枸杞子浓缩营养液及其制备方法 | |
| CN103416651A (zh) | 一种西洋参绞股蓝冲剂 | |
| CN103535725A (zh) | 一种果蔬保健品及其制备方法 | |
| CN106417817A (zh) | 一种袋泡助眠安神茶及其制备方法 | |
| CN102987192A (zh) | 一种可促进肠胃蠕动的蜂蜜浓汁及其制备方法 | |
| CN110024941A (zh) | 一种具有益气补血功能的组合物及其应用 | |
| CN105010628B (zh) | 一种女性减肥保健袋泡茶 | |
| CN103829240B (zh) | 一种含龙眼壳、核浸提液的明目保健品及其制备方法 | |
| CN1785053A (zh) | 一种缓解视疲劳的保健食品及其制备工艺 | |
| CN101164603A (zh) | 一种复方浓缩枸杞胶囊及其制备方法 | |
| CN110236035A (zh) | 一种枸杞山楂保健原浆及其应用 | |
| CN1114164A (zh) | 金枝玉液(或称果汁蛋)保健饮料 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210106 Address after: 157000 Yangming Economic Development Zone, Yangming District, Mudanjiang City, Heilongjiang Province Patentee after: HEILONGJIANG HEERSI PHARMACEUTICAL Co.,Ltd. Address before: 157099 No.7, Qiaotou village, Xinglong Town, Dong'an District, Mudanjiang City, Heilongjiang Province Patentee before: HEILONGJIANG YUEBANG FOOD Co.,Ltd. |
|
| TR01 | Transfer of patent right |